4//SEC Filing
Markels John 4
Accession 0001193805-24-000827
CIK 0001768224other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:00 PM ET
Size
9.9 KB
Accession
0001193805-24-000827
Insider Transaction Report
Form 4
Markels John
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-14+3,131→ 3,131 total - Award
Stock option (right to buy)
2024-06-14+15,000→ 15,000 totalExercise: $31.00Exp: 2034-06-14→ Common Stock (15,000 underlying) - Exercise/Conversion
Deferred Stock Units
2024-06-14−3,131→ 0 totalExercise: $0.00→ Common Stock (3,131 underlying)
Footnotes (3)
- [F1]Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024.
- [F2]Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
- [F3]Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
Documents
Issuer
Arcturus Therapeutics Holdings Inc.
CIK 0001768224
Entity typeother
Related Parties
1- filerCIK 0001803424
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 9:00 PM ET
- Size
- 9.9 KB